Cargando…

Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients

AIM: To investigate predictors for fibrosis specifically in a high risk population of morbidly obese patients, including detailed evaluation of lifestyle. METHODS: We conducted a cross-sectional study among morbidly obese patients attending the bariatric clinic at the Tel-Aviv Medical Center between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zelber-Sagi, Shira, Shoham, Dafna, Zvibel, Isabel, Abu-Abeid, Subhi, Shibolet, Oren, Fishman, Sigal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241533/ https://www.ncbi.nlm.nih.gov/pubmed/28144390 http://dx.doi.org/10.4254/wjh.v9.i2.91

Ejemplares similares

Discriminatory metabolic and inflammatory parameters in serum and omental adipose tissue of obese patients with different insulin sensitivity()
por: Khatib, Marian, et al.
Publicado: (2014)

Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis
por: Gotlieb, Neta, et al.
Publicado: (2020)

High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2022)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
por: Zelber-Sagi, Shira, et al.
Publicado: (2020)

Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease
por: Salomone, Federico, et al.
Publicado: (2020)

Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2019)

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Ultra-Processed Food Intake and Smoking Interact in Relation with Colorectal Adenomas
por: Fliss-Isakov, Naomi, et al.
Publicado: (2020)

Mediterranean dietary components are inversely associated with advanced colorectal polyps: A case-control study
por: Fliss-Isakov, Naomi, et al.
Publicado: (2018)

Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
por: Hadefi, Alia, et al.
Publicado: (2023)

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
por: Romero-Gómez, Manuel, et al.
Publicado: (2023)

Endoscopic treatment of early leaks and strictures after laparoscopic one anastomosis gastric bypass
por: Younis, Fadi, et al.
Publicado: (2020)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Body Image, Emotional Eating and Psychological Distress among Bariatric Surgery Candidates in Israel and the United States
por: Geller, Shulamit, et al.
Publicado: (2020)

GIPR Signaling in Immune Cells Maintains Metabolically Beneficial Type 2 Immune Responses in the White Fat From Obese Mice
por: Efimova, Irina, et al.
Publicado: (2021)

Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial
por: Deutsch, Liat, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease: A patient guideline
por: Francque, Sven M., et al.
Publicado: (2021)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Olteanu, Vasile-Andrei, et al.
Publicado: (2022)

Retrospective study of the associations between hepatitis C virus infection and metabolic factors
por: Yair-Sabag, Shira, et al.
Publicado: (2016)

Nutritional issues in patients with obesity and cirrhosis
por: Schiavo, Luigi, et al.
Publicado: (2018)

Patient satisfaction with primary care physician performance in a multicultural population
por: Hayek, Samah, et al.
Publicado: (2020)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer
por: Bar, Nir, et al.
Publicado: (2018)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
por: Almomani, Ashraf, et al.
Publicado: (2022)

Frailty status as a potential factor in increased postoperative opioid use in older adults
por: Auckley, Elizabeth D., et al.
Publicado: (2021)

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
por: Lazarus, Jeffrey V., et al.
Publicado: (2021)

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018)

Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study
por: Li, Rui, et al.
Publicado: (2017)

Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study
por: Levy, Nimrod Adatto, et al.
Publicado: (2020)

Vitamin D Deficiency in Patients with Morbid Obesity before and after Metabolic Bariatric Surgery
por: Musella, Mario, et al.
Publicado: (2022)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
por: Rabinowich, Liane, et al.
Publicado: (2015)

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pqfhaaecu3c1ehmpgep0v7624u